New technique predicts which melanoma patients are at risk for cancer recurrence, spread

(Brigham and Women's Hospital) Investigators from Brigham and Women's Hospital, in collaboration with international colleagues, present a new, quantitative technique that leverages DNA sequencing to make more sophisticated and accurate predictions about which primary melanomas are likely to recur and spread.